Literature DB >> 6742157

Influence of vasopressin on renal hemodynamics in conscious Brattleboro rats.

M Gellai, J H Silverstein, J C Hwang, F T LaRochelle, H Valtin.   

Abstract

The influence of vasopressin on renal hemodynamics was assessed by treating conscious Brattleboro homozygotes (DI rats) both acutely and chronically with physiologic doses of vasopressin. Intravenous infusions of vasopressin for 1 h, resulting in plasma vasopressin concentrations of less than 1.25, 2.3, and 8.0 pg/ml, respectively, failed to change glomerular filtration rate (GFR) or effective renal blood flow (ERBF) significantly, nor were there significant changes during 5 h of infusion. Body weight was not altered during these infusions. When synthetic vasopressin was given by osmotic minipumps for 10 days, with the rats gaining weight and thus changing the volume of their body fluids, GFR and ERBF increased significantly, by approximately 45 and 55%, respectively. Acute administration of volume alone, as well as acute vasopressin plus acute administration of volume, did not alter GFR or ERBF significantly. The data are compatible with the view that vasopressin, in physiologic plasma concentrations, exerts an influence on renal hemodynamics, that may be mediated through the long-term alteration of body fluid volumes. Alternatively or additionally, prolonged exposure of DI rats to vasopressin may increase their renal hemodynamics through tubuloglomerular feedback.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6742157     DOI: 10.1152/ajprenal.1984.246.6.F819

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Calcitonin has a vasopressin-like effect on aquaporin-2 trafficking and urinary concentration.

Authors:  Richard Bouley; Hua A J Lu; Paula Nunes; Nicolas Da Silva; Margaret McLaughlin; Ying Chen; Dennis Brown
Journal:  J Am Soc Nephrol       Date:  2010-11-11       Impact factor: 10.121

2.  Renal response to blood volume expansion in Brattleboro rats after acute treatment with vasopressin.

Authors:  R Palluk; A T Veress; H Sonnenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

3.  Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats.

Authors:  L A Danielson; K P Conrad
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 4.  Early diabetic nephropathy in type 1 diabetes: new insights.

Authors:  Petter Bjornstad; David Cherney; David M Maahs
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-08       Impact factor: 3.243

5.  Desensitization of rat renal thick ascending limb cells to vasopressin.

Authors:  J M Elalouf; D C Sari; N Roinel; C de Rouffignac
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

6.  Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33).

Authors:  W E Boertien; I J Riphagen; I Drion; A Alkhalaf; S J L Bakker; K H Groenier; J Struck; P E de Jong; H J G Bilo; N Kleefstra; R T Gansevoort
Journal:  Diabetologia       Date:  2013-04-28       Impact factor: 10.122

7.  Adaptation of the rat kidney to altered water intake and urine concentration.

Authors:  L Bankir; C Fischer; S Fischer; K Jukkala; H C Specht; W Kriz
Journal:  Pflugers Arch       Date:  1988-07       Impact factor: 3.657

Review 8.  Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.

Authors:  Petter Bjornstad; David Z Cherney; David M Maahs; Kristen J Nadeau
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

9.  Additive effects of glucagon and vasopressin on renal Mg reabsorption and urine concentrating ability in the rat.

Authors:  J M Elalouf; D C Sari; C de Rouffignac
Journal:  Pflugers Arch       Date:  1986       Impact factor: 3.657

10.  Sensitivities of rat kidney thick ascending limbs and collecting ducts to vasopressin in vivo.

Authors:  J M Elalouf; A Di Stefano; C de Rouffignac
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.